Patents by Inventor David Carley

David Carley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11972095
    Abstract: Various embodiments discussed herein enable client applications to be heavily integrated with a voice assistant in order to perform commands associated with voice utterances of users via voice assistant functionality and also seamlessly cause client applications to automatically perform native functions as part of executing the voice utterance. Such heavy integration also allows particular embodiments to support multi-modal input from a user for a single conversational interaction. In this way, client application user interface interactions, such as clicks, touch gestures, or text inputs are executed alternative or in addition to the voice utterances.
    Type: Grant
    Filed: October 22, 2021
    Date of Patent: April 30, 2024
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Tudor Buzasu Klein, Viktoriya Taranov, Sergiy Gavrylenko, Jaclyn Carley Knapp, Andrew Paul McGovern, Harris Syed, Chad Steven Estes, Jesse Daniel Eskes Rusak, David Ernesto Heekin Burkett, Allison Anne O'Mahony, Ashok Kuppusamy, Jonathan Reed Harris, Jose Miguel Rady Allende, Diego Hernan Carlomagno, Talon Edward Ireland, Michael Francis Palermiti, II, Richard Leigh Mains, Jayant Krishnamurthy
  • Publication number: 20130281523
    Abstract: The present invention provides methods for treating cannabinoid-sensitive disorders with a lose-dose oral cannabinoid which results in delivery of a therapeutic level during an extended clinically-relevant therapeutic window. These methods provide therapeutic dosing while maintaining safe, side effect sparing, levels of a cannabinoid. The present invention also provides methods of determining optimal dosing in treated patients.
    Type: Application
    Filed: November 18, 2011
    Publication date: October 24, 2013
    Inventors: Peter Letendre, David Carley
  • Publication number: 20120231083
    Abstract: The present invention provides a medicament which results in delivery of a therapeutic level of one or more cannabinoids during a clinically relevant therapeutic window. The therapeutic window is a longer window than provided by an immediate release medicament such as Marinol containing an equivalent amount of the cannabinoid. Oral administration of the present compositions provides therapeutic dosing while maintaining safe, side effect sparing, levels of a cannabinoid. The present invention also provides methods of treating cannabinoid-sensitive disorders.
    Type: Application
    Filed: May 17, 2012
    Publication date: September 13, 2012
    Applicants: The Board of Trustees of the University of Illinois, PIER PHARMACEUTICALS
    Inventors: David Carley, Kenton Fedde, John KOLENG, Peter LETENDRE
  • Publication number: 20070123517
    Abstract: The present invention relates generally to pharmacological methods for the prevention of amelioration of sleep-related breathing disorders via administration of agents or combinations of agents that possess serotonin-related pharmacological activity.
    Type: Application
    Filed: December 21, 2006
    Publication date: May 31, 2007
    Applicant: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
    Inventors: Miodrag Radulovacki, David Carley
  • Publication number: 20060241164
    Abstract: The present invention relates generally to pharmacological methods for the prevention or amelioration of sleep-related breathing disorders via administration of agents or combinations of agents that possess serotonin-related pharmacological activity.
    Type: Application
    Filed: April 14, 2006
    Publication date: October 26, 2006
    Applicant: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOI
    Inventors: Miodrag Radulovacki, David Carley